{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:32:29Z","timestamp":1791855149533,"version":"4.3.4"},"reference-count":46,"publisher":"Wiley","issue":"1pt2","license":[{"start":{"date-parts":[[2009,3,26]],"date-time":"2009-03-26T00:00:00Z","timestamp":1238025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Immunology"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The absence of complement receptor 1 (CR1) related gene\/protein y (Crry) leads to embryonic lethality as a result of unrestricted complement activation and concomitant neutrophil infiltration. Here we used <jats:italic>Crry<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup><jats:italic>C3<\/jats:italic><jats:sup>+\/\u2212<\/jats:sup> mice to investigate the role of Crry in the pathogenesis of immune complex glomerulonephritis (GN). After 3\u2003weeks of immunization with horse spleen apoferritin, six of nine <jats:italic>Crry<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup>\u2003<jats:italic>C3<\/jats:italic><jats:sup>+\/\u2212<\/jats:sup> mice and none of the six control <jats:italic>C3<\/jats:italic><jats:sup>+\/\u2212<\/jats:sup> mice developed proliferative GN (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7010). After 5\u2003weeks of immunization, GN scores in <jats:italic>Crry<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup>\u2003<jats:italic>C3<\/jats:italic><jats:sup>+\/\u2212<\/jats:sup> mice were 0\u00b767\u2003\u00b1\u20030\u00b722 mean \u00b1 standard error of the mean (SEM), compared with 0\u00b732\u2003\u00b1\u20030\u00b716 in <jats:italic>C3<\/jats:italic><jats:sup>+\/\u2212<\/jats:sup> mice. Glomerular hypercellularity was attributable to neutrophil infiltration in mice with GN (1\u00b77\u2003\u00b1\u20030\u00b73\/glomerulus) compared with those without GN (0\u00b74\u2003\u00b1\u20030\u00b71\/glomerulus) (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7001). Absent staining for \u03b1\u2010smooth muscle actin and proliferating cell nuclear antigen suggested that mesangial cell proliferation did not play a significant role in this model. Serum C3 levels in <jats:italic>Crry<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup>\u2003<jats:italic>C3<\/jats:italic><jats:sup>+\/\u2212<\/jats:sup> mice were approximately 20% and 30% those of wild\u2010type mice and <jats:italic>C3<\/jats:italic><jats:sup>+\/\u2212<\/jats:sup> mice, respectively. To determine whether this acquired hypocomplementaemia was relevant to this GN model system, <jats:italic>Crry<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup>\u2003<jats:italic>C3<\/jats:italic><jats:sup>+\/\u2212<\/jats:sup> mouse kidneys were transplanted into wild\u2010type mice followed by immunization with apoferritin for 1 or 2\u2003weeks. Surprisingly, none of the <jats:italic>Crry<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup>\u2003<jats:italic>C3<\/jats:italic><jats:sup>+\/\u2212<\/jats:sup> mouse kidneys developed GN at these early time\u2010points, indicating that increasing circulating C3 levels several\u2010fold did not increase susceptibility to GN. Renal expression of decay\u2010accelerating factor was not different among any of the groups studied. Thus, our data indicate that mesangial cell Crry limits complement activation and subsequent neutrophil recruitment in the setting of local immune complex deposition.<\/jats:p>","DOI":"10.1111\/j.1365-2567.2009.03102.x","type":"journal-article","created":{"date-parts":[[2009,3,26]],"date-time":"2009-03-26T15:51:11Z","timestamp":1238082671000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Mesangial cell complement receptor 1\u2010related protein y limits complement\u2010dependent neutrophil accumulation in immune complex glomerulonephritis"],"prefix":"10.1111","volume":"128","author":[{"given":"Lihua","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peili","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menaka","family":"Sarav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Minto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miglena","family":"Petkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Quigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,8,4]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200104053441406"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.181.1.151"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000051597.27127.A1"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.7.3601"},{"key":"e_1_2_8_6_2","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.4049\/jimmunol.160.9.4553","article-title":"Blockade of antibody\u2010induced glomerulonephritis with Crry\u2010Ig, a soluble murine complement inhibitor","volume":"160","author":"Quigg RJ","year":"1998","journal-title":"J Immunol"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.188.7.1321"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.287.5452.498"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006101176"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(03)00321-2"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.4.2732"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2008.09.003"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng912"},{"key":"e_1_2_8_14_2","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.4049\/jimmunol.151.8.4295","article-title":"Mouse Crry\/p65: characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF","volume":"151","author":"Li B","year":"1993","journal-title":"J Immunol"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI24521"},{"key":"e_1_2_8_16_2","first-page":"746","article-title":"Experimental glomerulonephritis in the mouse associated with mesangial deposition of autologous ferritin immune complexes","volume":"32","author":"Stilmant MM","year":"1975","journal-title":"Lab Invest"},{"key":"e_1_2_8_17_2","first-page":"772","article-title":"Immune complex acute necrotizing glomerulonephritis with progression to diffuse glomerulosclerosis. A murine model","volume":"59","author":"Iskandar SS","year":"1988","journal-title":"Lab Invest"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.4.2629"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1998.00723.x"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115089"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1369\/jhc.6A7000.2006"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000089831.96794.0B"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2006.06.023"},{"key":"e_1_2_8_24_2","first-page":"598","article-title":"Complement induction of decay accelerating factor on human mesangial cells: signal transduction pathways","volume":"4","author":"Cosio FG","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1159\/000075692"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006101125"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2001.01287.x"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.07.040189.000343"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.t01-1-00652.x"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004090778"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3700522"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.7.3319"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.11.5658"},{"key":"e_1_2_8_34_2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1681\/ASN.V125919","article-title":"Chemokine and chemokine receptor expression during initiation and resolution of immune complex glomerulonephritis","volume":"12","author":"Anders HJ","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00750.x"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.186.2.199"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.75.8.3943"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.02.040184.001353"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jcbfm.9600608"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707640"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10449"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.05-5814com"},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.5.3437"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.7.3883"},{"key":"e_1_2_8_45_2","first-page":"3012","article-title":"C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist","volume":"35","author":"Bao L","year":"2005","journal-title":"Eur J Immunol"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.3.1947"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707332"}],"container-title":["Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2567.2009.03102.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2567.2009.03102.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T23:12:10Z","timestamp":1697325130000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2567.2009.03102.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,4]]},"references-count":46,"journal-issue":{"issue":"1pt2","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1111\/j.1365-2567.2009.03102.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2567.2009.03102.x","archive":["Portico"],"relation":{},"ISSN":["0019-2805","1365-2567"],"issn-type":[{"value":"0019-2805","type":"print"},{"value":"1365-2567","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,4]]},"assertion":[{"value":"2009-08-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}